Financials
- Market Capitalization 579.26 M
- Employee 353
- Founded 2012
- CEO David Moatazedi
- Website www.evolus.com
- Headquarter Delaware, United States
- FIGI BBG005CX4HK8
- Industry 药品制造—专业与仿制药
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-8.31
市销率
1.44
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2786 | AQST Aquestive Therapeutics, Inc. - Common Stock | 5.00 USD | -3.10% | +7.30% | +33.69% | +30.55% | 627.56 M USD | ||
| 2792 | TLRY Tilray Brands, Inc. - Common Stock | 4.51 USD | -1.31% | -7.20% | +11.91% | +213.19% | 614.28 M USD | ||
| 2957 | KMDA Kamada Ltd. - Ordinary Shares | 8.26 USD | -1.43% | +1.60% | +17.33% | +17.83% | 476.49 M USD | ||
| 2987 | BIOA BioAge Labs, Inc. - Common Stock | 9.77 USD | -3.08% | +1.03% | -55.51% | +28.55% | 448.41 M USD |